{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-015592","form_type":"8-K","ticker":"DBVT","cik":"0001613780","company_name":"DBV Technologies S.A.","filed_at":"2026-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.644215+00:00","generated_at":"2026-05-16T09:33:04.866986+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"DBV Technologies secures €166.7M from full exercise of warrants after positive VITESSE trial","bullets":["€166.7M gross proceeds from full exercise of ABSA Warrants (34.1M) and BS Warrants (71.0M) issued March 2025.","Proceeds to fund BLA submission and U.S. launch preparations for VIASKIN Peanut patch in children 4-7 years if approved.","Company expects to be funded for at least 12 months, including through potential commercial launch.","Exercise triggered by positive VITESSE Phase 3 topline results announced December 16, 2025; no warrants remain outstanding.","59.7M new ordinary shares issued; additional pre-funded warrants may access up to 154M new shares in future."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-015592","json":"https://secwatch.observer/filing/0001193125-26-015592.json","markdown":"https://secwatch.observer/filing/0001193125-26-015592.md","text":"https://secwatch.observer/filing/0001193125-26-015592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613780/000119312526015592/0001193125-26-015592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613780/000119312526015592/d74681d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:33:04.866986+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}